secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2023-02-03T23:59:59+00:00
Accession:  0001214659-23-001612
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro receives Nasdaq deficiency notice for bid price below $1.00
--------------------------------------------------------------------------

- Received Nasdaq deficiency letter on Jan 30, 2023 for bid price below $1.00 for 30 consecutive days.
- Has 180 calendar days (until July 31, 2023) to regain compliance by closing at $1.00 for 10 consecutive business days.
- May request an additional 180-day compliance period if it meets other listing standards.
- No immediate effect on listing; common stock continues trading on Nasdaq under symbol ALZN.
- Company intends to monitor bid price and evaluate options to regain compliance, but cannot assure success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465923001612/0001214659-23-001612-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465923001612/d1312308k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-23-001612

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer